# Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

> **NCT05644184** · PHASE2 · RECRUITING · sponsor: **PATH** · enrollment: 2232 (estimated)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1)
- **BIOLOGICAL:** Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)

## Key facts

- **NCT ID:** NCT05644184
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-27
- **Primary completion:** 2026-05-15
- **Final completion:** 2026-05-15
- **Target enrollment:** 2232 (ESTIMATED)
- **Last updated:** 2026-01-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05644184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05644184, "Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05644184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*